PRR4: A Protein Involved in T Cell Regulation and Cancer Development
PRR4: A Protein Involved in T Cell Regulation and Cancer Development
PRR4 (PR interleukin-4), also known as PD-1伪, is a protein that is expressed in various tissues throughout the body, including immune cells, skin cells, and tissues. It plays a crucial role in the regulation of immune responses and has been implicated in the development and progression of several diseases, including cancer.
One of the most significant aspects of PRR4 is its role in the regulation of T cell responses. T cells are a vital part of the immune system and are responsible for detecting and responding to foreign substances in the body. PRR4 is involved in the regulation of T cell development, activation, and differentiation, and has been shown to play a role in the regulation of both CD4+ and CD8+ T cell responses.
In addition to its role in T cell regulation, PRR4 has also been shown to be involved in the regulation of inflammation and fibrosis. PRR4 has been shown to be involved in the regulation of inflammation by suppressing the production of pro-inflammatory cytokines. It has also been shown to play a role in the regulation of fibrosis by suppressing the production of extracellular matrix (ECM) components.
PRR4 has also been shown to have potential as a drug target in the treatment of several diseases, including cancer. For example, several studies have shown that inhibiting PRR4 can lead to increased T cell responses and improved immune function in cancer patients. Additionally, PRR4 has been shown to be involved in the regulation of cancer cell migration and invasion, which may have implications for the development of new cancer therapies.
In conclusion, PRR4 is a protein that has been shown to play a critical role in the regulation of T cell responses and inflammation, and has potential as a drug target for the treatment of several diseases, including cancer. Further research is needed to fully understand the role of PRR4 in these processes and to develop effective therapies based on its properties.
Protein Name: Proline Rich 4
More Common Targets
PRR5 | PRR5-ARHGAP8 | PRR5L | PRR7 | PRR7-AS1 | PRR9 | PRRC1 | PRRC2A | PRRC2B | PRRC2C | PRRG1 | PRRG2 | PRRG3 | PRRG4 | PRRT1 | PRRT2 | PRRT3 | PRRT3-AS1 | PRRT4 | PRRX1 | PRRX2 | PRSS1 | PRSS12 | PRSS16 | PRSS2 | PRSS21 | PRSS22 | PRSS23 | PRSS27 | PRSS3 | PRSS30P | PRSS33 | PRSS35 | PRSS36 | PRSS37 | PRSS38 | PRSS3P1 | PRSS3P2 | PRSS3P3 | PRSS40A | PRSS41 | PRSS42P | PRSS45P | PRSS46P | PRSS48 | PRSS50 | PRSS53 | PRSS54 | PRSS55 | PRSS56 | PRSS57 | PRSS58 | PRSS59P | PRSS8 | PRTFDC1 | PRTG | PRTN3 | PRUNE1 | PRUNE2 | PRX | PRXL2A | PRXL2B | PRXL2C | PRY | PRY2 | PRYP3 | PRYP4 | PSAP | PSAPL1 | PSAT1 | PSAT1P1 | PSAT1P3 | PSCA | PSD | PSD2 | PSD3 | PSD4 | PSEN1 | PSEN2 | PSENEN | PSG1 | PSG10P | PSG11 | PSG2 | PSG3 | PSG4 | PSG5 | PSG6 | PSG7 | PSG8 | PSG9 | PSIP1 | PSKH1 | PSKH2 | PSMA1 | PSMA2 | PSMA3 | PSMA3-AS1 | PSMA3P1 | PSMA4